Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abcellera Biologics Inc
(NQ:
ABCL
)
3.850
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abcellera Biologics Inc
< Previous
1
2
3
4
5
6
Next >
Why AbCellera Biologics Stock Sank 21.6% in October
November 04, 2021
The biotech is now down roughly 56% across 2021's trading.
Via
The Motley Fool
The Next Challenge For Covid Stocks Is Also A Cash Cow For These Companies
October 15, 2021
Companies working on sorely needed Covid treatments are innovating to keep up.
Via
Investor's Business Daily
Why AbCellera Biologics Stock Jumped 19.4% Last Month
October 07, 2021
Despite last month's gains, the biotech stock is now down roughly 61% year to date.
Via
The Motley Fool
AbCellera, Everest Medicines Team Up To Develop 10 Therapeutic Antibodies
September 23, 2021
AbCellera Biologics Inc (NASDAQ: ABCL) and Everest Medicines Limited have entered into a multi-year collaboration and license agreement to discover...
Via
Benzinga
Cramer's Advice On Ulta Beauty, Laredo Petroleum And More
September 23, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer to buy more Ulta Beauty Inc (NASDAQ: ULTA). He likes the stock very much. Cramer doesn't like...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Analyzing AbCellera Biologics's Unusual Options Activity
August 03, 2021
Shares of AbCellera Biologics (NASDAQ:ABCL) saw some unus...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
A Day Of Huge Market Moves
September 21, 2021
It was a day of huge market moves and several reporting companies. Trudeau won but did not get a parliamentary majority.
Via
Talk Markets
15 Stocks Moving in Friday's Pre-Market Session
September 17, 2021
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) rose 42% to $3.21 in pre-market trading. AbCellera Biologics Inc. (NASDAQ: ABCL) rose 18% to $23.35 in pre-market trading....
Via
Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
AbCellera Stock Is Moving Higher After Expanded Use Nod For Lilly-Partnered COVID-19 Antibody
September 17, 2021
The FDA has expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis in...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why AbCellera Biologics Stock Jumped 7% on Wednesday
September 15, 2021
The company's drug-development technology is starting to attract attention.
Via
The Motley Fool
Exposures
COVID-19
AbCellera Shares Are Moving Higher On Licensing Pact With Moderna
September 15, 2021
AbCellera Biologics Inc (NASDAQ: ABCL) has entered into a research collaboration and license agreement with Moderna Inc (NASDAQ: MRNA) for antibodies for...
Via
Benzinga
A Weak Week
September 10, 2021
Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants.
Via
Talk Markets
Here's Why AbCellera Biologics Stock Gained 10.6% Last Month
September 04, 2021
Even with its recent gains, the biotech stock is down roughly 53.4% in 2021's trading.
Via
The Motley Fool
Why AbCellera Biologics Stock Was Up More Than 17% on Friday
August 13, 2021
The biopharma company's second quarter was better than expected. The future looks pretty bright, too.
Via
The Motley Fool
78 Biggest Movers From Friday
August 16, 2021
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...
Via
Benzinga
AbCellera Biologics Inc. (ABCL) Q2 2021 Earnings Call Transcript
August 13, 2021
ABCL earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
53 Stocks Moving In Friday's Mid-Day Session
August 13, 2021
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand...
Via
Benzinga
More Greek Variants To Follow
August 12, 2021
Nokia will supply the Western Power District with private long-term evolution fast 5G grid for trials.
Via
Talk Markets
Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?
August 12, 2021
One particular group of stocks is overrepresented among the exchange's biggest losers this year. That's an important detail.
Via
The Motley Fool
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg
August 04, 2021
SoftBank Group Corp (OTC: SFTBF) has quietly acquired a $5 billion stake in Roche Holdings AG (OTC: RHHBF), making it one of the largest investors of the Roche,...
Via
Benzinga
Analyzing AbCellera Biologics's Unusual Options Activity
July 29, 2021
AbCellera Biologics (NASDAQ:ABCL) shares experienced unusual options activity on Thursday. The stock price moved up to $16.32 following the option alert. Sentiment: BEARISH...
Via
Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
July 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 20, 2021
Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the largest, in terms of market cap, to set a new 52-week low....
Via
Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.